A5.5 Hybrid non-cellular capital adjustment

Guidance

1.

This section acts to limit hybrid non-cellular capital to 15% of an Insurer's adjusted non-cellular equity.

2.

The purpose of the hybrid non-cellular capital adjustment is to limit the extent to which an Insurer may rely for its Adjusted Non-Cellular Capital Resources on instruments that do not or may not constitute permanent capital of the Insurer. Such instruments include share capital contributed by a Holding Company, where the Holding Company's investment is financed by debt rather than by its own capital.

97

PIN VER07.290725

A5.5.1 Subject to Rule A5.5.2, hybrid non-cellular capital includes the following items:

(a)